Cost-utility analysis of TNF-alpha inhibitors, B-cell inhibitors and JAK inhibitors versus csDMARDs for Rheumatoid Arthritis treatment Post date July 19, 2024 ← Therapeutic impact of aerobic exercise on obese adolescents and its association with expression of miRNAs and cytokines: A Clinical Approach → Earth Mover’s Distance-Based Automated Disease Tagging of Indian ECGs